Indomethacin enhances the cytotoxicity of recombinant human lymphotoxin α on tumor cells by suppressing NFκB signaling

Cancer Biology and Therapy

Volumn 6, Issue 9, 2007, Pages 1428-1433

  Shen, Yijun ^a   Yang, Tong ^a   Wang, Jing ^a   Xu, Qing ^b   Li, Rong ^b   Pan, Wei ^c   Li, Gang ^a   Wang, Zheng ^a   Tan, Jingwei ^a   Wu, Jinsong ^a   Wu, Fang ^a   Wang, Luochun ^a   Liu, Yanjun ^a  

^a Shanghai Fudan Zhangjiang Bio pharmaceutical Co Ltd   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; Cytokines; Indomethacin; Inflammation; Lymphotoxin ; Nuclear factor kappa B; Tumor therapy

Indexed keywords

CISPLATIN; DOXORUBICIN; FLICE INHIBITORY PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOMETACIN; LYMPHOTOXIN; RECOMBINANT HUMAN LYMPHOTOXIN ALPHA; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHILL; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG POTENTIATION; FEVER; HUMAN; HUMAN CELL; LOW DRUG DOSE; PREMEDICATION; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

EID: 42549170070     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.6.9.4559     Document Type: Article

References (40)